Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1245087

Furosemide and spironolactone doses and hyponatremia in patients with heart failure.


Velat, Ivan; Bušić, Željko; Jurić Paić, Marina; Čulić, Viktor
Furosemide and spironolactone doses and hyponatremia in patients with heart failure. // BMC Pharmacology and Toxicology, 21 (2020), 1; 57-57 doi:10.1186/s40360-020-00431-4 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1245087 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Furosemide and spironolactone doses and hyponatremia in patients with heart failure.

Autori
Velat, Ivan ; Bušić, Željko ; Jurić Paić, Marina ; Čulić, Viktor

Izvornik
BMC Pharmacology and Toxicology (2050-6511) 21 (2020), 1; 57-57

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Diuretics ; Furosemide ; Heart failure ; Hyponatremia ; Spironolactone.

Sažetak
Background: Hyponatremia, a marker of disease severity and prognosis, has been associated with various clinical factors and drug use, especially diuretics. Methods: This observational prospective cohort study enrolled patients hospitalized at the University Hospital Center Split because of heart failure (HF). We investigated the association of clinical variables and cardiovascular drugs, including furosemide, hydrochlorothiazide, spironolactone, and their doses, with the presence of hyponatremia at admission. Results: Of the 565 included patients, 32.4% were hyponatremic, 62.6% were males, and the mean age was 73.1 ± 10.6 years. In the univariate analysis, hyponatremic patients were more often current smokers (p = 0.01), alcohol consumers (p = 0.01), receiving spironolactone (p = 0.004) or combination of furosemide and spironolactone (p = 0.003). Patients who received 50 and 100 mg of spironolactone, compared to those receiving 25 mg (p < 0.0001), as well as patients who received 250 to 500 mg of furosemide compared to ≤240 mg (p = 0.001), were significantly more often hyponatremic. In the multivariate analysis, when diuretic doses were accounted for, furosemide doses of 250 to 500 mg (p = 0.009), spironolactone doses of 50 to 100 mg (p = 0.0003), increasing age (p = 0.03), diabetes mellitus (p = 0.02) and alcohol consumption (p = 0.04) were independently associated with hyponatremia. Conclusion: High doses of furosemide and spironolactone, or concomitant use of these diuretics, seem to be an important cause of hyponatremia in HF patients, particularly in combination with advanced age, diabetes and alcohol consumption. Diuretic dose reduction may help avoid hyponatremia and improve clinical status and prognosis in such patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Željko Bušić (autor)

Avatar Url Viktor Čulić (autor)

Avatar Url Marina Jurić Paić (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Velat, Ivan; Bušić, Željko; Jurić Paić, Marina; Čulić, Viktor
Furosemide and spironolactone doses and hyponatremia in patients with heart failure. // BMC Pharmacology and Toxicology, 21 (2020), 1; 57-57 doi:10.1186/s40360-020-00431-4 (međunarodna recenzija, članak, znanstveni)
Velat, I., Bušić, Ž., Jurić Paić, M. & Čulić, V. (2020) Furosemide and spironolactone doses and hyponatremia in patients with heart failure.. BMC Pharmacology and Toxicology, 21 (1), 57-57 doi:10.1186/s40360-020-00431-4.
@article{article, author = {Velat, Ivan and Bu\v{s}i\'{c}, \v{Z}eljko and Juri\'{c} Pai\'{c}, Marina and \v{C}uli\'{c}, Viktor}, year = {2020}, pages = {57-57}, DOI = {10.1186/s40360-020-00431-4}, keywords = {Diuretics, Furosemide, Heart failure, Hyponatremia, Spironolactone.}, journal = {BMC Pharmacology and Toxicology}, doi = {10.1186/s40360-020-00431-4}, volume = {21}, number = {1}, issn = {2050-6511}, title = {Furosemide and spironolactone doses and hyponatremia in patients with heart failure.}, keyword = {Diuretics, Furosemide, Heart failure, Hyponatremia, Spironolactone.} }
@article{article, author = {Velat, Ivan and Bu\v{s}i\'{c}, \v{Z}eljko and Juri\'{c} Pai\'{c}, Marina and \v{C}uli\'{c}, Viktor}, year = {2020}, pages = {57-57}, DOI = {10.1186/s40360-020-00431-4}, keywords = {Diuretics, Furosemide, Heart failure, Hyponatremia, Spironolactone.}, journal = {BMC Pharmacology and Toxicology}, doi = {10.1186/s40360-020-00431-4}, volume = {21}, number = {1}, issn = {2050-6511}, title = {Furosemide and spironolactone doses and hyponatremia in patients with heart failure.}, keyword = {Diuretics, Furosemide, Heart failure, Hyponatremia, Spironolactone.} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font